DST antibodies are immunoreagents designed to detect dystonin, a plakin family protein involved in anchoring intermediate filaments to cellular structures. DST has three major isoforms:
DST-a: Neuronal isoform, critical for maintaining cytoskeletal integrity in sensory neurons .
DST-b: Muscular isoform, essential for striated muscle maintenance .
DST-e: Epithelial isoform, anchoring keratin filaments to hemidesmosomes .
Mutations in DST are linked to hereditary sensory and autonomic neuropathy type VI (HSAN-VI) and epidermolysis bullosa simplex (EBS) . DST antibodies are used to study these pathologies and validate protein expression across tissues .
Western Blot (WB): Detects DST isoforms (e.g., ~861 kDa full-length protein) in tissues such as brain (mouse/rat) and liver cancer samples .
Immunohistochemistry (IHC): Localizes DST in formalin-fixed paraffin-embedded tissues, with antigen retrieval recommended for optimal results .
Immunofluorescence (IF): Visualizes DST in cultured cells (e.g., SH-SY5Y neuroblastoma cells) .
Disease Modeling: Used to investigate DST-related disorders, such as HSAN-VI and EBS, in mouse models .
Interaction Studies: Identified binding partners like collagen XVII, MAP1B, and erbin, elucidating DST’s role in cytoskeletal organization .
HSAN-VI: Loss of DST-a2 disrupts neuronal autophagy, leading to sensory neuropathy .
EBS: DST-e deficiency causes skin blistering due to hemidesmosome instability .
DST-b Mutations: Cause late-onset protein aggregate myopathy and cardiomyopathy in mice, characterized by desmin aggregation and mitochondrial dysfunction .
Donor-Specific Transfusion (DST): Preclinical studies show DST combined with anti-CD154 antibodies prolongs allograft survival in nonhuman primates .
Dilution Ranges:
Validation: Ensure isoform specificity (e.g., DST-a vs. DST-b) using knockout controls .
DST antibodies have revealed novel disease mechanisms: